Dr. Dai has dedicated over a decade to advancing both basic research and clinical practice in the field of glioma, a complex and challenging type of brain tumor that demands a multidisciplinary approach to improve patient outcomes. Throughout his 10-plus years of professional engagement, he has developed a profound expertise in the comprehensive management of brain glioma, with a particular focus on integrating core treatment modalities—including precise surgical resection to maximize tumor removal while preserving neurological function, personalized radiotherapy regimens tailored to individual tumor characteristics, evidence-based chemotherapy protocols, and cutting-edge targeted therapy strategies that aim to address specific molecular drivers of tumor growth. His commitment to bridging the gap between laboratory discoveries and clinical application has not only enhanced his ability to provide high-quality care to patients but also positioned him as a key contributor to advancing glioma treatment standards.​ In the realm of scientific research, Dr. Dai has demonstrated exceptional leadership and productivity. He has taken the lead in overseeing more than 10 high-impact research projects, among which are initiatives funded by the National Natural Science Foundation of China (NSFC)—a prestigious funding body that supports innovative, high-caliber scientific inquiry. His research endeavors have yielded a remarkable body of academic work: he has published over 100 academic papers in peer-reviewed journals, with a significant focus on translating research findings into actionable clinical insights. Over the past five years alone, he has authored or co-authored more than 30 papers indexed in the Science Citation Index (SCI), a benchmark of international academic excellence, and these publications collectively boast a total impact factor exceeding 280. This impressive metric reflects the broad influence and high regard his work has received within the global neuroscience and oncology communities. Additionally, his research impact is further underscored by an H-index of 28 (as reported by Google Scholar), a measure that quantifies both the productivity and citation impact of a researcher’s publications, placing him among the most influential scholars in his field.​ Beyond his research and clinical work, Dr. Dai plays an active and vital role in shaping academic discourse and supporting the peer-review process. He holds concurrent editorial roles across more than 10 Chinese and English-language journals, serving as Associate Editor, Editorial Board Member, and Young Editorial Board Member—positions that allow him to guide the direction of academic publishing, mentor early-career researchers, and ensure the dissemination of high-quality, rigorous research. Furthermore, he contributes his expertise as a reviewer for over 40 prominent journals, where he evaluates the scientific merit, methodological soundness, and originality of submitted manuscripts, thereby upholding the integrity of the academic publishing ecosystem.​ Dr. Dai’s contributions extend beyond the written word and editorial work. He has participated in the compilation of one academic monograph, sharing his specialized knowledge to support the education and training of future generations of clinicians and researchers. His innovative spirit is also evident in his work translating research into practical solutions: he has been awarded 18 authorized national invention patents, which reflect his ability to develop novel technologies, devices, or approaches that have the potential to improve glioma diagnosis, treatment, or patient care.​ His exceptional achievements have been recognized through numerous prestigious awards and honors. He is the recipient of the Second Prize of the Jiangsu Provincial Medical Science and Technology Award, an accolade that acknowledges outstanding contributions to advancing medical science and technology in the province, and the First Prize of the Jiangsu Provincial Health Commission Medical New Technology Introduction Award, which highlights his success in introducing and implementing innovative medical technologies that enhance clinical practice. At the provincial level, he has been honored with the title of “Advanced Individual” by the Anhui Anti-Cancer Association, in recognition of his dedicated service and contributions to the fight against cancer in Anhui Province, and “Outstanding Young Neurosurgeon of Anhui Province” by the Neurosurgery Branch of the Anhui Medical Doctor Association—a testament to his exceptional skills, leadership, and promise as a young leader in the field of neurosurgery. Collectively, these experiences, achievements, and honors solidify Dr. Dai’s reputation as a distinguished clinician-scientist whose work continues to make a meaningful impact on glioma research, treatment, and patient care.